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Depression is associated with worse patency
and recurrent leg symptoms after lower
extremity revascularization
Gregory S. Cherr, MD,a,b Jiping Wang, MD, PhD,a,c Pamela M. Zimmerman, MD,a
and Hasan H. Dosluoglu, MD,a Buffalo, NY
Objectives:Depression is associated with worse outcomes after coronary artery bypass surgery, but its association with the
results after revascularization for symptomatic peripheral arterial disease (PAD) is unknown. This study assessed the
association between depression and patency, recurrent symptoms, and limb salvage after revascularization for symptom-
atic PAD.
Methods: Electronic medical records were retrospectively reviewed for all patients with symptomatic PAD who underwent
intervention (open, endovascular, or combined) between January 2000 and October 2004. All patients were previously
screened for depression, and treatment was initiated as indicated by the primary care physician or psychiatrist.
Demographic data and outcomes were recorded using published guidelines. Outcomes of interest included primary
patency of the revascularization (bypass graft or angioplasty/stented artery), assisted primary patency, secondary patency,
recurrent symptomatic ipsilateral PAD, and major amputation. Follow-up was available for all patients (mean, 23.4 
14.1 months).
Results: Board-certified vascular surgeons performed all interventions. At the time of intervention, 78 (36.1%) of 216
patients had been diagnosed with depression. Compared with those without depression, depressed patients were younger
(64.4 vs 69.1 years; P  .001), currently using tobacco (74.4% vs 51.4%; P  .001), and less likely to have hypertension
(79.5% vs 89.9%; P  .03). No other significant differences were noted for cardiovascular risk factors or prevalent
comorbidities. During follow-up, 50 patients (23.1%) had failing or failed revascularizations, and 24 (11%) had
amputations. Those with depression at the time of the PAD intervention, compared at 24 months with patients without
depression, had significantly worse primary patency (58.2% vs 79.8%; P .02), primary assisted patency (59.5% vs 81.5%;
P  .01), and secondary patency (60.2% vs 82.2%; P  .007). They also had a significantly increased risk of recurrent
symptomatic PAD (33.7% vs 20.8%; P  .03) but not major amputation (13.8% vs 10.4%; P  .73). By multivariate
analysis, patients with depression were at significantly increased risk for recurrent symptomatic PAD (hazard ratio [HR],
1.77; 95% confidence interval [CI], 1.03 to 3.02; P  .04) and failure of revascularization (HR, 2.18; 95% CI, 1.22 to
3.88; P < .01), but not major amputation.
Conclusions: Depression is common among patients undergoing intervention for symptomatic PAD. After intervention,
patients with depression have worse outcomes for the affected leg. Prospective analysis is required to confirm these results.
(J Vasc Surg 2007;45:744-50.)Depression is associated with worse outcomes for pa-
tients with coronary artery disease and is a risk factor for
recurrent cardiovascular events and mortality after myocar-
dial infarction.1 Depression is common among patients
undergoing coronary artery bypass grafting (CABG) sur-
gery, with as many as 43% of patients experiencing signifi-
cant depressive symptoms before surgery.2 After CABG,
patients with depression are at increased risk for recurrent
cardiovascular events,3,4 rehospitalization for cardiac events,5
repeat coronary revascularization,4 poor functional status,4-7
and death.8-10 Although numerous reports have demon-
strated an association between depression and outcome
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744after CABG, no previous studies to our knowledge have
examined the relationship between depression and results
after lower extremity revascularization for symptomatic
peripheral arterial disease (PAD).
The objectives of this study were to assess the preva-
lence of depression among patients with symptomatic PAD
undergoing revascularization and the association between
depression and patency, recurrent leg symptoms, and limb
salvage after revascularization for symptomatic PAD. The
study hypotheses were that depression is common among
patients with symptomatic PAD and patients with depres-
sion at the time of intervention will have worse outcomes
for the revascularized extremity compared with patients
without depression.
METHODS
Between January 2000 and October 2004, 219 pa-
tients underwent an intervention for chronic symptomatic
aortoiliac, or femoropopliteal or femorotibial artery occlu-
sive PAD, or both, at the Western New York Veteran’s
Administration (VA) Hospital and were eligible for inclu-
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from the Institutional Review Board for Human Subjects
Research at the Western New York VA Hospital.
Excluded from the study were three patients who were
unable to complete the depression evaluation because of
severe dementia (n  2) and chronic schizophrenia and
aphasia (n  1). Thus, 216 patients met the inclusion
criteria (symptomatic atherosclerotic occlusive PAD, ability
to complete a depression evaluation) and formed the basis
of this report. A retrospective electronic medical record
review was completed for all patients. Preoperative vari-
ables, periprocedural results, and long-term outcome data
were gathered using recommended reporting standards.11,12
Follow-up data were available for all patients (mean 23.4
14.1 months).
For this study, depression was defined as significant
depressive symptoms resulting in a recommendation for
treatment with antidepressant medication or psychosocial
therapy, or both. Depression was diagnosed by the primary
care provider or a psychiatrist before the decision was made
to intervene for symptomatic PAD. Because depression is
frequently underdiagnosed and undertreated,13 VA proto-
col mandates that all patients should be screened for de-
pression using a two-part protocol. The initial evaluation
was performed using the General Health Questionnaire-
12, a screening tool with good reliability and validity that is
widely used in primary care.14 A score of 3 resulted in
further evaluation by the patient’s primary health care
provider before the diagnosis of depression was made. This
depression screening is repeated annually.
Board-certified vascular surgeons performed all inter-
ventions. The indications for revascularization included
disabling claudication in 62 patients (28.7%), ischemic rest
pain in 48 (22.2%), and tissue loss in 106 (49.1%). Inter-
ventions included open surgery in 123 patients (56.9%),
percutaneous revascularization in 68 (31.5%), and com-
bined open/endovascular procedures in 25 (11.6%).
After revascularization, patients were examined at 3
months, and then at 6-month intervals for clinical assess-
ment, which included femoral and distal pulses and recur-
rence of ipsilateral symptoms, and a vascular laboratory
examination, which included ankle-brachial index (ABI)
measurements, graft or stent velocities, and duplex imag-
ing. At each examination, patients were queried about
incident PAD events, including care received at private-
sector hospitals.
The vascular laboratory studies were reviewed for all
patients to confirm the patency of the revascularization.
Angiography and repeat intervention were performed
when clinically indicated. Patients who missed vascular
clinic appointments were contacted by phone to ascertain
clinical status and reschedule follow-up visits.
The primary outcome was primary patency of the by-
pass graft or endovascular reconstruction, and secondary
outcomes included primary assisted patency, secondary pa-
tency, and major amputation. These outcomes were de-
fined using accepted standards.11,12Finally, recurrent symptoms in the revascularized leg
were assessed as a marker of long-term clinical success, an
outcome used in other vascular territories.15 Relief of
symptoms is an important goal for both the patient and
clinician and does not necessarily correlate with patency:
some patients have an asymptomatic graft occlusion and
others have recurrent symptoms owing to progression of
PAD in another vascular bed. The diagnosis of recurrent
symptoms was defined as initial relief of symptoms with
subsequent recurrence based on patient history (claudica-
tion, rest pain, or tissue loss) and confirmed by a physical
examination showing a change in peripheral pulse results,
presence of ulceration or gangrene, or a vascular laboratory
study showing a reduction of ABI of0.10 frommaximum
postprocedural value or graft occlusion, or both. To verify
the distinction between vascular and nonvascular causes of
symptoms, the relationship between symptoms and PAD
was confirmed by arteriogram revealing new atherosclerotic
occlusive lesions or graft occlusion, or intraoperative find-
ings of graft occlusion.
The statistical analysis was conducted with SAS 9.1
software (SAS Institute, Cary, NC). Patients’ baseline char-
acteristics were reported using descriptive statistics. For
patients with and without depression, the demographics,
comorbid illnesses, and clinical signs/symptoms were com-
pared using 2 test for categoric variables and the Student
t test for continuous variables. The log rank test was used to
evaluate the association between depression and the out-
comes after intervention.16
Univariate and multivariate analysis were used to assess
the relationship between preoperative factors and out-
comes of interest. The variables included were age, depres-
sion, previous cardiac disease, previous lower extremity revas-
cularization, prior carotid endarterectomy, prior CABG
surgery, prior percutaneous coronary intervention, diabetes,
tobacco use ever, current tobacco use or 1 year, hyperten-
sion, dyslipidemia, current statin use, carotid disease, renal
disease, pulmonary disease, cerebrovascular disease, site of
intervention (aortoiliac, femoropopliteal, femorotibial), in-
dication for intervention (disabling claudication, rest pain,
tissue loss), and type of intervention (endovascular, open,
hybrid). The relative risk for these variables on the selected
outcomes was estimated using the Cox proportional hazard
model with adjustment for other confounders that may
effect the outcome.17 All P values are reported as two-sided
with significant  level  0.05.
RESULTS
During the study period, 216 patients (99.5% men)
underwent intervention for symptomatic PAD. Their mean
age was 67.4 10.5 years (range, 41.0 to 89.3 years), and
87.5% were white, 11.6% were African American, and 1%
was Hispanic. At the time of intervention, 78 patients
(36.1%) had been previously diagnosed with depression,
and 58 were receiving antidepressant medications (74.4%),
2 (2.6%) were treated with only psychosocial counseling,
and 18 (23.1%) refused treatment for depression. The small
number of patients in each group precluded subgroup
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treatment, or antidepressant medication.
At the time of intervention, the patient demographics,
prevalent diseases, and prior vascular interventions were
similar for patients with and without depression (Table I);
however, patients with depression were significantly
younger than nondepressed patients (64.4  10.8 years vs
69.1 9.9 years; P .001). Patients with depression were
less likely to require antihypertensive therapy (79.5% vs
89.9%; P  .03). Although depressed patients were more
likely than nondepressed patients to have used tobacco
within 1 year (74.4% vs 51.4%; P  .001) and during their
lifetime (94.9% vs 84.1%; P  .02), they were less fre-
quently diagnosed with pulmonary disease (26.9% vs
53.6%; P  .0001).
The indications for intervention, type of procedure,
and site of vascular disease were similar for both groups of
patients (Table II). Periprocedural outcomes were not sig-
nificantly different for depressed patients compared with
nondepressed patients for 30-day mortality (1.3% vs 5.1%;
P  .16) or complications (17.9% vs 23.9%; P  .31). No
differences were noted between depressed and nonde-
pressed patients for ABI before intervention (0.40  0.22
vs 0.37  0.19; P  .30) and after intervention (0.82 
0.21 vs 0.85  0.16; P  .22). The ABI for patients with
depression rose from 0.40  0.22 to 0.82  0.21 (P 
.0001) after revascularization and increased from 0.37 
0.19 to 0.85  0.16 (P  .0001) for nondepressed pa-
tients.
Follow-up data were available for all patients, during
Table I. Demographics and comorbid illnesses for
patients undergoing intervention for symptomatic
peripheral arterial disease
Variable
Depressed
(%)
Nondepressed
(%) P
Age (years) 64.4 69.1 .001
Race
White 92.3 84.8 .30
African American 7.7 13.8
Hispanic 0 1.4
Diabetes 44.9 52.2 .30
Hypertension 79.5 89.9 .03
Dyslipidemia 59 64.5 .42
Statin use 50.0 57.2 .31
Tobacco use
Ever 94.9 84.1 .02
1 year 74.4 51.4 .001
Coronary artery disease 66.7 64.5 .75
Cerebrovascular disease 29.5 36.2 .31
Previous procedure
Coronary revascularization 18.0 23.2 .37
CEA 9.0 9.4 .91
LE revascularization 23.8 21.7 .82
Contralateral amputation 5.1 5.1 .98
Renal disease 21.8 29.0 .21
Pulmonary disease 26.9 53.6 .0001
CEA, Carotid endarterectomy; LE, lower extremity.which 50 patients (23.1%) had failing or failed revascular-izations, 56 (25.9%) had recurrent symptomatic PAD, and
24 (11%) underwent major amputation. Of the 56 patients
with recurrent symptoms, 18 (32.1%) had a patent recon-
struction with progression of PAD in a separate vascular
bed, and 38 (67.9%) had an associated loss of patency.
Although 12 patients had failing or failed reconstructions
(one patient with an asymptomatic failing graft and 11
patients with thrombosed revascularizations), they were
not included in the analysis for recurrent symptoms because
the events occurred before complete wound healing and
were therefore not “recurrent.” During follow-up, no pa-
tients were noted to have PAD interventions at private-
sector hospitals.
Patients with depression at the time of revascularization
had worse patency of the revascularization compared with
those without depression. By product-limit estimate, pa-
tients with depression had significantly worse primary pa-
tency (24 months; 58.2% vs 79.8%; P  .02; Fig 1), primary
assisted patency (24 months; 59.5% vs 81.5%; P  .01; Fig
2), and secondary patency (24 months; 60.2% vs 82.2%; P
 .007; Fig 3).
With univariate analysis, factors significantly associated
with worse primary patency rate included depression (haz-
ard ratio [HR], 1.91; 95% confidence interval [CI], 1.10 to
3.38; P  .02), prior coronary artery disease events (HR,
2.00; 95% CI, 1.05 to 3.81; P  .04), aortoiliac vs femo-
ropopliteal/femorotibial operation (HR, 0.374; 95% CI,
0.26 to 0.54; P  .0001), endovascular vs hybrid/open
operation (HR, 0.58; 95% CI, 0.37 to 0.90; P  .01), and
indication for operation (HR, 0.44; 95% CI, 0.22 to 0.90;
P  .02).
By multivariate analysis, significant and independent
predictors for failure of primary patency included depres-
sion (HR, 2.18; 95% CI, 1.22 to 3.88; P  .01), prior
coronary artery disease events (HR, 2.11; 95% CI, 1.10 to
4.09; P  .03), femoropopliteal revascularization (HR,
2.63; 95% CI, 1.13 to 6.10; P  .03), and femorotibial
revascularization (HR, 7.43; 95% CI, 3.33 to 16.59; P 
Table II. Summary of indications for intervention and
operative management in 216 patients
Variable
Depressed
(%)
Nondepressed
(%) P
Indication for intervention
Claudication 23.1 31.1 .40
Rest pain 25.6 20.3
Tissue loss 50.0 49.3
Site of reconstruction*
Aortoiliac 42.3 52.1 .15
Femoropopliteal 42.3 27.5
Femorodistal 20.5 29.7
Type of reconstruction
Open surgery 55.1 58.0 .88
Percutaneous procedure 32.1 31.2
Hybrid procedure 9.0 10.9
*Seventeen patients underwent combined aortoiliac and infrainguinal re-
construction; therefore, the percentage of patients for each group is100%..001). The results of multivariate analysis of predictors of
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those for primary patency (data not shown).
Depression was also associated with an increased risk
for recurrent leg symptoms after revascularization. The
product-limit estimate of time to recurrent symptoms
was significantly worse for patients with depression at the
time of intervention (24 months; 33.7% vs 20.8%; P 
Fig 1. Product-limit estimates of time to primary failure of recon-
struction for 78 patients with depression (dotted line) and 138
without depression (solid line) at the time of intervention. The
primary patency rate was significantly worse for patients with
depression.
Fig 2. Product-limit estimates of time to primary assisted failure
of reconstruction for 78 patients with depression (dotted line) and
138 without depression (solid line) at the time of intervention. The
primary assisted patency rate was significantly worse for patients
with depression..03; Fig 4).Univariate analysis showed that factors significantly
associated with recurrent leg symptoms were depression
(HR, 1.81; 95% CI, 1.06 to 3.08; P  .03), statin therapy
(HR, 0.57; 95% CI, 0.34 to 0.97; P  .04), femorodistal
revascularization (HR, 2.72; 95% CI, 1.40 to 5.28; P 
.003), open/hybrid repair (HR, 4.13; 95% CI, 1.63 to
Fig 3. Product-limit estimates of time to secondary failure of
reconstruction for 78 patients with depression (dotted line) and
138 without depression (solid line) at the time of intervention. The
secondary patency rate was significantly worse for patients with
depression.
Fig 4. Product-limit estimates of freedom from recurrent ipsilat-
eral leg symptoms for 78 patients with depression (dotted line) and
138 without depression (solid line) at the time of intervention.
Patients with depression were at significantly increased risk for
recurrent leg symptoms.10.42; P  .003), and claudication (HR, 0.45; 95% CI,
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depression significantly and independently predicted recur-
rent symptoms (HR, 1.77; 95% CI, 1.03 to 3.02; P .04),
and claudication as an indication for intervention, com-
pared with rest pain or tissue loss, was associated with
decreased risk for recurrent symptoms (HR, 0.49; 95% CI,
0.26 to 0.92; P  .03).
When compared with nondepressed patients, de-
pressed patients were not at increased risk for major ampu-
tation. The product-limit estimate of time to amputation
was not significantly different between the two groups (24
months; 13.8% vs 10.4%; P  .73).
DISCUSSION
Depression is associated with poorer outcomes for pa-
tients undergoing CABG; however, to our knowledge, no
previous research has examined the influence of depression
on outcomes after lower extremity revascularization. In the
present study, 216 patients underwent intervention for
symptomatic PAD. At the time of revascularization, 78
patients (36.1%) had been diagnosed with depression.
Depressed patients were younger andmore likely to use
tobacco but otherwise had similar atherosclerotic risk factors
and comorbid conditions at the time of intervention. The
two groups had similar indications for intervention, types of
intervention, and periprocedural outcomes. Patients with
depression had poorer primary patency of the vascular
reconstruction, however, and were at increased risk for
symptomatic ipsilateral progression of PAD. Multivariate
analysis showed that depression was a significant and inde-
pendent predictor of ipsilateral progression of PAD and
failure of the revascularization. Depression was not associ-
ated with major amputation, perhaps related to the small
number of events during the follow-up period.
Although no previous reports have examined the im-
pact of depression on outcomes after lower extremity revas-
cularization, multiple studies have found worse outcomes
for patients with depression undergoing CABG.3-10 Similar
to the present study, depression was associated with pro-
gression of coronary artery disease and recurrent symptoms
in a number of reports. Connerney et al3 observed 309
patients for 1 year after CABG and found that depression
was a significant and independent predictor of recurrent
cardiovascular events. With 5-year follow-up of 172 pa-
tients after CABG, Borowicz et al4 noted that perioperative
depression was associated with recurrent chest pain and
repeat coronary revascularization.4 Another group assessed
depression before CABG and prospectively followed 111
patients after surgery. The authors noted that depression
was associated with recurrent hospitalization for cardiovas-
cular events at 6 months5 and with cardiovascular death
with 2-year follow-up.6
Previous research has examined the biologic plausibility
of an association between depression and adverse cardiac
events.18 Biologic mechanisms are present in patients with
depression and can increase the risk for cardiovascular
events. These include dysregulation of the hypothalamic-
pituitary axis and autonomic nervous system, a commongenetic vulnerability to depression and coronary heart dis-
ease events; increased platelet activation, and increased
levels of catecholamine, and serotonin.18 The association
between depression and worse cardiac outcomes may also
be mediated by behavioral mechanisms, including non-
compliance with diet, medical, or exercise therapy.18 Fur-
ther evaluation is needed to understand if these associations
also exist for patients with PAD.
Finally, in 2003 the results were published of a random-
ized trial that examined the association between treatment
of depression after myocardial infarction and recurrent
myocardial infarction or death. Compared with patients
getting “best medical care,” no reduction in event-free
survival was found in those receiving depression therapy.19
Prospective trials are necessary to understand the associa-
tion between depression therapy, PAD symptoms, and
outcomes after PAD intervention.
In the present study, the prevalence of depression
among patients undergoing lower extremity revasculariza-
tion was 36.1%. No previous reports have evaluated the
prevalence rate of patients undergoing intervention for
symptomatic PAD, and the rate of depression among this
patient population was higher than expected.
Results from studies examining the association between
depression and PAD in patients with both symptomatic and
asymptomatic PAD are conflicting. A recent population-
based study of patients aged 60 found no association
between PAD and depression, noting that 8.1% of patients
with PAD (ABI 0.90) had depressive symptoms com-
pared with 6.5% of patients without PAD (P  NS).20
Arseven et al,21 however, found that significantly more
patients with ABI-diagnosed PAD (24%) had depressive
symptoms compared with those without PAD (12%).
Another study from the same group described the
association between symptomatic and asymptomatic PAD,
depression, and lower extremity functioning.22 They noted
that 21.7% of patients with PAD had a clinically significant
number of depressive symptoms. The authors found that
the proportion of patients with “leg pain with exertion and
rest” rose significantly with increasing number of depres-
sive symptoms. Adjusting for age, race, ABI, number of
comorbid conditions, smoking status, and antidepressant
drug use, an increasing number of depressive symptoms
was also associated with poorer lower extremity function-
ing.22
It should be noted that severely symptomatic PAD,
such as in the present study, is characterized by conditions
associated with depressive symptoms, such as chronic
pain,23 functional disability, and multiple medical comor-
bidities.24 Given the results of the present study and previ-
ous research, the high prevalence of depression among
patients with symptomatic PAD should be confirmed by
prospective trials.
Previous research has examined the prevalence of de-
pression in other patient populations undergoing interven-
tion for an acute medical illness. Depression was present in
27% to 47% of patients before they underwent CABG
procedures.25,26 Before craniotomy for treatment of a brain
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pressive symptoms.27 Overall, approximately 25% of pa-
tients diagnosed with cancer have depression.28 In the
present study, 36% of patients undergoing intervention for
symptomatic PAD had been diagnosed with depression, a
similar proportion to other patient populations.
The finding in the present study that tobacco use did
not predict outcome in the affected limb was unexpected.
Previous research has identified an association between
tobacco use and poor results after leg revascularization.29
In the present study, recent tobacco use or lifetime history
of tobacco was not associated with the outcomes of inter-
est. This was most likely due to the high prevalence of
tobacco abuse in both depressed and nondepressed pa-
tients.
The present study has several limitations. Because of its
retrospective design, the results are based on the selected
data available in the medical record. However, the VA
computerized medical record includes data from all inpa-
tient and outpatient contacts, so that it is unlikely that
significant medical events within the VA Hospital system
were overlooked.
Patients may have obtained medical care outside the
VA Hospital system. We did not review medical records
from private-sector hospitals in the region. We believe,
however, that it is unlikely that the presence or absence of
depression would effect a patient’s decision to seek care
from another hospital. Therefore, private-sector care did
not likely significantly influence the results of this study.
The conclusions of this report may not be generalizable
to women, because the present patient population included
only one woman (0.5%). For this retrospective study, data
regarding socioeconomic status, activity level and body
mass index were unavailable, all of which may have im-
pacted the associations reported in the study.
Finally, patients were diagnosed with depression before
the decision was made to intervene for symptomatic PAD.
Therefore, some patients in the depression cohort may not
have been depressed at the time of intervention but were
still receiving antidepressant therapy. Other patients may
have developed significant depressive symptoms between
the time of depression screening and vascular intervention,
yet were not included in the depression group. Although
the interval between depression diagnosis and leg revascu-
larization may weaken the associations observed, it should
not affect the overall findings of the study.
Prospective data are needed to elaborate on the find-
ings of the present study. Serial assessment of depressive
symptoms before and after intervention would result in a
more complete understanding of the relationship between
depression, depressive symptoms, and symptomatic PAD.
As part of a study to assess changes in quality of life after
PAD intervention, Johnson et al30 found that patients
undergoing surgical bypass (but not angioplasty) had im-
provement in depressive symptoms.
Concomitant evaluation of chronic pain and functional
disability would also be important because these factors are
associated with depressive symptoms. In a study of patientswith PAD not undergoing intervention, an increasing
number of depressive symptoms were associated with worse
leg functioning and more leg pain with exertion and at
rest.22 Understanding the influence of revascularization on
these associations would provide important information for
the clinician caring for patients with symptomatic PAD.
CONCLUSION
Depression is common among patients undergoing
intervention for symptomatic PAD. Screening for depres-
sion may be of benefit for patients with symptomatic PAD.
Depression is associated with worse outcomes after revas-
cularization, with poorer patency and increased risk for
recurrent leg symptoms.
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